InvestorsHub Logo
Followers 18
Posts 6668
Boards Moderated 0
Alias Born 03/06/2010

Re: Couch post# 249978

Friday, 04/07/2017 7:24:01 AM

Friday, April 07, 2017 7:24:01 AM

Post# of 402086
I get the ER vs IR, but IR is not just an Elite issue. That is what I am hung up on. Any pharma with a potential ADT IR product would be held to this bar if that were the case. May just be funny wording, "ER or rest of industry". That is solely focused on Elite.

"So this is not an issue that the FDA is going to expand I believe to ER or the rest of the industry. It was a unique thing in this very specific case that they thought about two years after they give us green light to move forward. So there will be no real formulation for any of our ER products or anybody in the industry that for the reasons I just explained.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News